TruAlt Bioenergy logo

TruAlt Bioenergy financials: balance sheet, profit and loss, cash flow

NSE: TRUALTBSE: 544545Agricultural Food & other ProductsSmall Cap

TruAlt Bioenergy Limited · Face value ₹10 · Listed Oct 2025 · Issue price ₹496
Last close ₹359.60down ₹15.50 (4.13%)BSE ₹360.30

Share price at the NSE close on 30 Oct 2026. Previous close ₹375.10.

30 Oct: open ₹375.55, high ₹375.55, low ₹356.00

52-week range of traded prices to 30 Oct 2026
₹310.20Low, 27 Jan 2026₹542.00High, 10 Jun 2026
Market cap
₹3,084 Cr890th largest listed
P/E
13.95
P/B
1.90
Dividend yield
Nonein the last 12 months
ROE
14.6%
ROCE
11.8%
Debt to equity
0.98
Volume, NSE
2,33,48278.8% delivered

TruAlt Bioenergy's financial statements for the year to Mar 2026, consolidated: the company and its subsidiaries together, with the half year to Sep 2026 after them.

1 year at a glance

₹ crore, years to March.TruAlt Bioenergy annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
1,728971,646Mar 26

Operating and net margin, per cent

  • Operating margin
  • Net margin
16.8%5.6%16.8%5.6%Mar 26

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue1,728
  2. Materials and goods−1,114
  3. Employee costs−48
  4. Other expenses−275
  5. Operating profit290
  6. Depreciation−86
  7. Other income+86
  8. One-off items0.0
  9. Finance costs−160
  10. Profit before tax130
  11. Tax−33
  12. Net profit97

What the company owns

  • Plant, investments and other assets₹2,750 Cr
  • Inventory₹528 Cr
  • Receivables₹406 Cr
  • Cash and bank₹90 Cr
  • Current investments₹4 Cr

What pays for it: net worth and liabilities

  • Borrowings₹1,646 Cr
  • Net worth₹1,578 Cr
  • Other liabilities₹282 Cr
  • Owed to suppliers₹272 Cr

Profit and loss

Consolidated, ₹ crore, years to March. The last column is the twelve months to Sep 2026, the latest four quarters added.TruAlt Bioenergy quarterly results

₹ croreMar 2026Sep 2026Twelve monthsFiled 23 Oct
Revenue from operations1,7282,747
1,4382,260
Materials and goods bought1,1141,811
Employee costs4850
Other expenses275399
Operating profit before depreciation290487
Operating margin16.8%17.7%
Materials, % of revenue64.5%65.9%
Employee costs, % of revenue2.8%1.8%
Other expenses, % of revenue15.9%14.5%
Depreciation and amortisation8694
Operating profit after depreciation204393
Other income8676
Finance costs160170
One-off items00
Profit before tax130299
3375
97224
Other comprehensive income00
Total comprehensive income97225
Net margin5.6%8.2%

Balance sheet

Consolidated, ₹ crore, at 31 March. The last column is the half year to Sep 2026, after the latest full year: the balance sheet at its end.

₹ croreMar 2026Sep 2026Half yearFiled 23 Oct
1,5781,687
1,5201,619
Share capital8686
Reserves1,4351,533
Belonging to outside owners of subsidiaries5868
1,6461,653
1,085850
1,1151,083
3,7783,620
2,3002,232
1,4791,195
Net debt1,5521,619
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only.

Cash flow

Consolidated, ₹ crore, years to March. The last column is the half year to Sep 2026, after the latest full year: the cash flow over its six months.

₹ croreMar 2026Sep 2026Half year
−289192
−281194
−654−65
Receivables−6739
Inventories−318322
Payables−214−220
Other working capital−55−205
Tax paid−8−3
Capital spending511183
Free cash flow−8009
−420−179
648−73
Dividends paid00
Shares bought back00
Shares issued6661
Net change in cash−62−61
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2026
Earnings per share₹12.30
Diluted earnings per share₹12.30
Book value per share₹177.29
Shareholder yield−19.2%
Market cap at the year end (₹ crore)3,459

Ratios

Consolidated, years to March.TruAlt Bioenergy PE ratio and valuation

RatioMar 2026
Return on equity6.3%
Return on capital employed6.3%
Cash conversion−298.6%
Interest cover1.3
Debt to equity1.04
Receivable days86
Inventory days173
Payable days89
Cash conversion cycle, days170
Working capital days202
Asset turnover0.46
Assets per rupee of net worth2.49
Sales per rupee of plant0.84
Capital spending to depreciation5.92
Plant being built, % of plant in use3.3%

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
2.5%
Cash from operations against operating profit
−99.8%

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations−289
Cash from investing−420
Cash from financing648
Capital spending511
Dividends paid0
Shares bought back0
Shares issued for cash666
Borrowings raised225
Borrowings repaid128

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2026
Altman Z-scorePublished threshold 1.812.31
Effective tax ratePublished threshold 17.16 per cent25.46
Tax charged less tax paid, % of profitOur threshold 10 percentage points19.15
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
13 Aug 2026CRISIL Ratings LimitedBank FacilitiesCrisil A-Review, Re-affirmNegative204
4 Jun 2026Acuite Ratings & Research LimitedIssuer RatingsACUITE BBReview, Downgrade
27 Apr 2026India Ratings and Research Private LimitedBank loan facilitiesLong and short-term scalesIND A-; IND A2+New, NewStable1,766
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.